sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
28-Jul-2014 06:31
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 776-800 out of 855.

<< < 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 > >>

Public Release: 27-Sep-2012
Controlling the spread of diseases among humans, other animals and the environment
West Nile virus, Lyme disease and hantavirus are all infectious diseases spreading in animals and in people. Is human interaction with the environment somehow responsible for the increase in incidence of these diseases?

Contact: Cheryl Dybas
National Science Foundation

Public Release: 27-Sep-2012
International Journal of Critical Infrastructures
Sandia probability maps help sniff out food contamination
Uncovering the sources of fresh food contamination could become faster and easier thanks to analysis done at Sandia National Laboratories' National Infrastructure Simulation and Analysis Center (NISAC).
Department of Homeland Security

Contact: Stephanie Holinka
DOE/Sandia National Laboratories

Public Release: 27-Sep-2012
Study highlights the burden of epilepsy in the developing world
The burden of epilepsy in poorer parts of the world could be readily alleviated by reducing the preventable causes and improving access to treatment, according to a review article funded by the Wellcome Trust.
Wellcome Trust

Contact: Jen Middleton
Wellcome Trust

Public Release: 26-Sep-2012
GW receives record 5-year, $134 million grant to study type 2 diabetes medications
John Lachin, professor of biostatistics, epidemiology and statistics at the George Washington University, has been awarded a five-year, $134 million grant from the National Institute of Health's National Institute of Diabetes and Digestive and Kidney Diseases to conduct a clinical trial examining the long-term effectiveness of several glucose-lowering medications for treatment of people with type 2 diabetes. The grant sets a record as the largest sum award GW has ever received.
NIH/National Institute of Diabetes and Digestive and Kidney Diseases

Contact: Latarsha Gatlin
George Washington University

Public Release: 25-Sep-2012
PLOS Medicine
PLOS Medicine editors comment on progress of World Health Report 2012
In this month's editorial, the PLOS Medicine Editors comment on the World Health Organization's (WHO) latest World Health Report, originally planned for publication in 2012, and the outcomes of the journal's collaboration with WHO on the intended theme of "no health without research."

Contact: Sumrina Yousufzai

Public Release: 25-Sep-2012
PLOS Medicine
Large donors are forcing the World Health Organization to reform
The current practice of large donors is forcing the World Health Organization and the World Bank to reflect on how to reform to remain more appealing to the wider set of stakeholders and interests at play, according to Devi Sridhar from the University of Oxford writing in this week's PLOS Medicine.

Contact: Sumrina Yousufzai

Public Release: 24-Sep-2012
World Heart Federation says heart health starts earlier than you think
A new multi-national survey reveals the extent of misconceptions about when is the right time to start taking action to prevent cardiovascular disease. In a four-country survey sample of 4,000 adults, 49 percent answered age 30 years or older when asked at what age they believe people should start to take action about their heart health to prevent conditions such as heart disease and stroke.

Contact: Charanjit K. jagait
World Heart Federation

Public Release: 23-Sep-2012
International Congress for Tropical Medicine and Malaria
Brazil, FIOCRUZ and DNDi Latin America partner to fight neglected diseases
At the opening ceremony of the XVIII International Congress for Tropical Medicines and Malaria and the XLVIII Congress of the Brazilian Society of Tropical Medicine in Rio de Janeiro, the Ministry of Health of Brazil signed a Cooperation and Technical Assistance Agreement with the Oswaldo Cruz Foundation and the Drugs for Neglected Diseases initiative Latin America, uniting the three actors into a strategic partnership to collaborate on research and development for new therapies and diagnostics for neglected diseases.

Contact: Mariana Abdalla
Drugs for Neglected Diseases Initiative

Public Release: 20-Sep-2012
$20 million gift launches new hub for global health at UCSF
The University of California, San Francisco has received a $20 million gift from philanthropist Chuck Feeney to build a new hub for Global Health Sciences at the UCSF Mission Bay campus. Feeney made the gift through The Atlantic Philanthropies, the foundation he created in 1982.

Contact: Kristen Bole
University of California - San Francisco

Public Release: 20-Sep-2012
New strategies needed to combat disease in developing countries
So-called lifestyle diseases are gaining ground with epidemic speed in low-income countries. The traditional health focus in these countries has been to combat communicable diseases such as malaria, HIV and tuberculosis. However, research from the University of Copenhagen suggests that dividing campaigns into combating either non-communicable or communicable diseases is ineffective and expensive. A new article by Danish scientists published in the well-reputed journal Science provides an overview.

Contact: Professor Ib Bygbjerg
University of Copenhagen

Public Release: 20-Sep-2012
Sanofi and TB Alliance announce collaboration to accelerate new tuberculosis treatments
Sanofi and the Global Alliance for TB Drug Development announced today a new research collaboration agreement to accelerate the discovery and development of novel compounds against tuberculosis, a deadly infectious disease that resulted in almost 1.5 million deaths worldwide in 2010. Under the agreement, Sanofi and TB Alliance will collaborate to further optimize and develop several novel compounds in Sanofi's library that have demonstrated activity against Mycobacterium tuberculosis, the bacterium that causes TB.

Contact: Derek Ambrosino
TB Alliance

Public Release: 19-Sep-2012
Science Translational Medicine
BIDMC and Diagnostics For All create first low-cost, paper-based, point of care liver function test
A new postage stamp-sized, paper-based device could provide a simple and reliable way to monitor for liver damage at a cost of only pennies per test, say researchers at Beth Israel Deaconess Medical Center (BIDMC) and Diagnostics For All (DFA), a Cambridge, MA nonprofit dedicated to improving the health of people living in the developing world.
Department of Defence, National Institutes of Health, Gates Foundation

Contact: Kelly Lawman
Beth Israel Deaconess Medical Center

Public Release: 19-Sep-2012
Autism symptoms could arise from unreliable neural responses
Diverse symptoms associated with autism could be explained by unreliable activity of neurons in the brain in response to basic, nonsocial sensory information, according to a study published by Cell Press on September 19th in the journal Neuron. The new findings suggest that autism is a disorder of general neural processing and could potentially provide an explanation for the origins of a range of psychiatric and neurological disorders.

Contact: Elisabeth (Lisa) Lyons
Cell Press

Public Release: 17-Sep-2012
Diabetes Care
Risk of developing diabetes higher in neighborhoods that aren't walk-friendly: Study
Whether your neighborhood is conducive to walking could determine your risk for developing diabetes, according to a new study by researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences.

Contact: Kate Taylor
St. Michael's Hospital

Public Release: 17-Sep-2012
EMBO Molecular Medicine
Scientists reveal how natural antibiotic kills tuberculosis bacterium
A natural product secreted by a soil bacterium shows promise as a new drug to treat tuberculosis report scientists in a new study published in EMBO Molecular Medicine. A team of scientists working in Switzerland has shown how pyridomycin, a natural antibiotic produced by the bacterium Dactylosporangium fulvum, works. This promising drug candidate is active against many of the drug-resistant types of the tuberculosis bacterium that no longer respond to treatment with the front-line drug isoniazid.

Contact: Barry Whyte
European Molecular Biology Organization

Public Release: 13-Sep-2012
UCLA's Aydogan Ozcan lauded as one of world's most brilliant innovators by Popular Science
Popular Science magazine has named Aydogan Ozcan, an associate professor of electrical engineering and bioengineering at UCLA, one of the world's "Brilliant 10" scientists in its October 2012 issue.

Contact: Matthew Chin
University of California - Los Angeles

Public Release: 13-Sep-2012
Journal of Biological Chemistry
Mutation breaks HIV's resistance to drugs
The human immunodeficiency virus (HIV) can contain dozens of different mutations, called polymorphisms. In a recent study an international team of researchers, including MU scientists, found that one of those mutations, called 172K, made certain forms of the virus more susceptible to treatment. Soon, doctors will be able to use this knowledge to improve the drug regiment they prescribe to HIV-infected individuals.

Contact: Tim Wall
University of Missouri-Columbia

Public Release: 13-Sep-2012
Journal of American Chemical Society
IU chemist develops new synthesis of most useful, yet expensive, antimalarial drug
In 2010 malaria caused an estimated 665,000 deaths, mostly among African children. Now, chemists at Indiana University have developed a new synthesis for the world's most useful antimalarial drug, artemisinin, giving hope that fully synthetic artemisinin might help reduce the cost of the live-saving drug in the future.
Indiana University

Contact: Steve Chaplin
Indiana University

Public Release: 13-Sep-2012
PLOS Pathogens
Scripps Research scientists reveal how deadly virus silences immune system
Scientists at The Scripps Research Institute have determined the structure of a critical protein from the Marburg virus, a close cousin of Ebola virus. These viruses cause similar diseases and are some of the deadliest pathogens on the planet, each killing up to 90 percent of those infected.
Burroughs Wellcome Fund, Skaggs Institute for Chemical Biology at The Scripps Research Institute

Contact: Mika Ono
Scripps Research Institute

Public Release: 13-Sep-2012
'Saving brains' in developing countries: $11.8 million for innovative ideas worldwide
With the goal of helping children in resource-poor countries meet their full intellectual potential, 11 projects in Asia, Africa and South America will receive in all some $11.8 million from the Government of Canada via Grand Challenges Canada to test innovations to address four impediments to cognitive development -- inadequate nurturing, nutrition deficiency, premature birth, and infection.
Grand Challenges Canada

Contact: Terry Collins
Sandra Rotman Centre for Global Health

Public Release: 11-Sep-2012
Proceedings of the National Academy of Sciences
Genetic make-up of children explains how they fight malaria infection
Researchers from Sainte-Justine University Hospital Center and University of Montreal have identified several novel genes that make some children more efficient than others in the way their immune system responds to malaria infection.

Contact: William Raillant-Clark
University of Montreal

Public Release: 11-Sep-2012
Dengue Vaccine Initiative welcomes latest progress in vaccine development
Today, the Dengue Vaccine Initiative welcomed new clinical trial results that reveal progress in developing the first-ever dengue vaccine. In a publication in the Lancet, pharmaceutical company Sanofi Pasteur reported results from the first study conducted to evaluate the efficacy of any dengue vaccine candidate against clinical dengue disease in a population naturally exposed to dengue.

Contact: Johanna Harvey
Sabin Vaccine Institute

Public Release: 11-Sep-2012
Journal of Antimicrobial Chemotherapy
Diet could combat adverse side-effects of quinine
Scientists at the University of Nottingham say adverse side-effects caused by the anti-parasitic drug quinine in the treatment of malaria could be controlled by what we eat.

Contact: Lindsay Brooke
University of Nottingham

Public Release: 11-Sep-2012
European Heart Journal
Results from world's first registry of pregnancy and heart disease
Results from the world's first registry of pregnancy and heart disease have shown that most women with heart disease can go through pregnancy and delivery safely, so long as they are adequately evaluated, counseled and receive high quality care. However, the research published in the European Heart Journal shows there are important differences: Mothers and babies in developing countries are more likely to die than those in developed countries, and women with cardiomyopathy also have worse outcomes.
European Society of Cardiology

Contact: Emma Mason
European Society of Cardiology

Public Release: 11-Sep-2012
PLOS Medicine
Blood transfusion services in Africa should suit local contact -- funders take note
"Flexibility and pragmatism are necessary to reduce the unacceptably high rates of unnecessary deaths in Africa because blood for transfusion is lacking," according to a group of 20 international authors from high-, middle- and low-income countries writing in this week's PLOS Medicine.

Contact: Sumrina Yousufzai

Showing releases 776-800 out of 855.

<< < 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 > >>